Trulieve Cannabis Corp. (TRLV) stock analysis

TRLV · Trulieve Cannabis Corp.

Latest recorded price: USD 10.33

Model-estimated fair value: USD 4.53. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

At $10.33, TRLV trades 128.2% above the model's base-case value of $4.53. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $3.73 in the conservative case and $5.41 in the optimistic case, with a valuation confidence score of 45/100. Fiscal 2025 figures: revenue growth -1.6%, free cash flow margin 19.4%, ROIC 11.2%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare